Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

tumor-associated macrophages; TME, tumor microenvironment; Tregs, regulatory T cells. Strategies to Boost CAR-T Cell Efficacy in CRC Fig 3. Advancements in CAR-T cell therapies for CRC. This figure ...

Rakesh Jain Ph.D., Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk ...

Lunit’s SCOPE HER2 AI model demonstrated an 86.7% accuracy compared to pathologist assessments for HER2 immunohistochemistry (IHC).

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelis®) with ...

Key Laboratory of Precision and Intelligent Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China Hefei National Research Center for ...

PDAC tumoes can be further classified into several subtypes based on gene expression and the surrounding tumor microenvironment ... chronic IFN signaling, macrophage activity, and plasmacytoid ...